336 related articles for article (PubMed ID: 37120350)
1. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
Davis K; Sheikh T; Aggarwal N
Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.
Li JF; Dai YT; Lilljebjörn H; Shen SH; Cui BW; Bai L; Liu YF; Qian MX; Kubota Y; Kiyoi H; Matsumura I; Miyazaki Y; Olsson L; Tan AM; Ariffin H; Chen J; Takita J; Yasuda T; Mano H; Johansson B; Yang JJ; Yeoh AE; Hayakawa F; Chen Z; Pui CH; Fioretos T; Chen SJ; Huang JY
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11711-E11720. PubMed ID: 30487223
[TBL] [Abstract][Full Text] [Related]
3. High incidence of RAS pathway mutations among sentinel genetic lesions of Korean pediatric BCR-ABL1-like acute lymphoblastic leukemia.
Lee JW; Kim Y; Cho B; Kim S; Jang PS; Lee J; Cho H; Lee GD; Chung NG; Kim M
Cancer Med; 2020 Jul; 9(13):4632-4639. PubMed ID: 32378810
[TBL] [Abstract][Full Text] [Related]
4. Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.
Paietta E; Roberts KG; Wang V; Gu Z; Buck GAN; Pei D; Cheng C; Levine RL; Abdel-Wahab O; Cheng Z; Wu G; Qu C; Shi L; Pounds S; Willman CL; Harvey R; Racevskis J; Barinka J; Zhang Y; Dewald GW; Ketterling RP; Alejos D; Lazarus HM; Luger SM; Foroni L; Patel B; Fielding AK; Melnick A; Marks DI; Moorman AV; Wiernik PH; Rowe JM; Tallman MS; Goldstone AH; Mullighan CG; Litzow MR
Blood; 2021 Sep; 138(11):948-958. PubMed ID: 33895809
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy.
Jeha S; Choi J; Roberts KG; Pei D; Coustan-Smith E; Inaba H; Rubnitz JE; Ribeiro RC; Gruber TA; Raimondi SC; Karol SE; Qu C; Brady SW; Gu Z; Yang JJ; Cheng C; Downing JR; Evans WE; Relling MV; Campana D; Mullighan CG; Pui CH
Blood Cancer Discov; 2021 Jul; 2(4):326-337. PubMed ID: 34250504
[TBL] [Abstract][Full Text] [Related]
6. International Consensus Classification of acute lymphoblastic leukemia/lymphoma.
Duffield AS; Mullighan CG; Borowitz MJ
Virchows Arch; 2023 Jan; 482(1):11-26. PubMed ID: 36422706
[TBL] [Abstract][Full Text] [Related]
7. Updates on lymphoblastic leukemia/lymphoma classification and minimal/measurable residual disease analysis.
Kovach AE; Wood BL
Semin Diagn Pathol; 2023 Nov; 40(6):457-471. PubMed ID: 37953192
[TBL] [Abstract][Full Text] [Related]
8. Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04-16.
Ohki K; Takahashi H; Fukushima T; Nanmoku T; Kusano S; Mori M; Nakazawa Y; Yuza Y; Migita M; Okuno H; Morimoto A; Yoshino H; Kato M; Hayashi Y; Manabe A; Ohara A; Hasegawa D; Inukai T; Tomizawa D; Koh K; Kiyokawa N;
Genes Chromosomes Cancer; 2020 Oct; 59(10):551-561. PubMed ID: 32368831
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia.
Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Marinakis T; Kostopoulos IV; Stiakaki E; Polychronopoulou S; Paterakis G
Int J Lab Hematol; 2019 Jun; 41(3):364-372. PubMed ID: 30730614
[TBL] [Abstract][Full Text] [Related]
10. Sequential Approach to Improve the Molecular Classification of Childhood Acute Lymphoblastic Leukemia.
Yu CH; Wu G; Chang CC; Jou ST; Lu MY; Lin KH; Chen SH; Wu KH; Huang FL; Cheng CN; Chang HH; Hedges D; Wang JL; Yen HJ; Li MJ; Chou SW; Hung CT; Lin ZS; Lin CY; Chen HY; Ni YL; Hsu YC; Lin DT; Lin SW; Yang JJ; Pui CH; Yu SL; Yang YL
J Mol Diagn; 2022 Nov; 24(11):1195-1206. PubMed ID: 35963521
[TBL] [Abstract][Full Text] [Related]
11. Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort.
Zaliova M; Stuchly J; Winkowska L; Musilova A; Fiser K; Slamova M; Starkova J; Vaskova M; Hrusak O; Sramkova L; Stary J; Zuna J; Trka J
Haematologica; 2019 Jul; 104(7):1396-1406. PubMed ID: 30630978
[TBL] [Abstract][Full Text] [Related]
12. Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing.
Migita NA; Jotta PY; Nascimento NPD; Vasconcelos VS; Centoducatte GL; Massirer KB; Azevedo AC; Brandalise SR; Yunes JA
Blood Adv; 2023 Jul; 7(13):2957-2971. PubMed ID: 36848637
[TBL] [Abstract][Full Text] [Related]
13. CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways.
Moreno Lorenzana D; Juárez Velázquez MDR; Reyes León A; Martínez Anaya D; Hernández Monterde A; Salas Labadía C; Navarrete Meneses MDP; Zapata Tarrés M; Juárez Villegas L; Jarquín Ramírez B; Cárdenas Cardós R; Herrera Almanza M; Paredes Aguilera R; Pérez Vera P
J Pathol Clin Res; 2021 Jul; 7(4):410-421. PubMed ID: 33890726
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Two Quantitative PCR-Based Assays for Detection of Minimal Residual Disease in B-Precursor Acute Lymphoblastic Leukemia Harboring Three Major Fusion Transcripts.
Huang YJ; Kuo MC; Jaing TH; Liu HC; Yeh TC; Chen SH; Lin TL; Yang CP; Wang PN; Sheen JM; Chang TK; Chang CH; Hu SF; Huang TY; Wang SC; Wu KH; Chiou SS; Hsiao CC; Shih LY
J Mol Diagn; 2021 Oct; 23(10):1373-1379. PubMed ID: 34325057
[TBL] [Abstract][Full Text] [Related]
15. Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on
Hrabovsky S; Vrzalova Z; Stika J; Jelinkova H; Jarosova M; Navrkalova V; Martenek J; Folber F; Salek C; Horacek JM; Pospisilova S; Mayer J; Doubek M
Acta Oncol; 2021 Jun; 60(6):760-770. PubMed ID: 33750258
[TBL] [Abstract][Full Text] [Related]
16. RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children.
Chen D; Camponeschi A; Nordlund J; Marincevic-Zuniga Y; Abrahamsson J; Lönnerholm G; Fogelstrand L; Mårtensson IL
Cancer Med; 2021 Jun; 10(12):3997-4003. PubMed ID: 33987955
[TBL] [Abstract][Full Text] [Related]
17. Predicting interactome network perturbations in human cancer: application to gene fusions in acute lymphoblastic leukemia.
Hajingabo LJ; Daakour S; Martin M; Grausenburger R; Panzer-Grümayer R; Dequiedt F; Simonis N; Twizere JC
Mol Biol Cell; 2014 Dec; 25(24):3973-85. PubMed ID: 25273558
[TBL] [Abstract][Full Text] [Related]
18. ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype.
Zaliova M; Kotrova M; Bresolin S; Stuchly J; Stary J; Hrusak O; Te Kronnie G; Trka J; Zuna J; Vaskova M
Genes Chromosomes Cancer; 2017 Aug; 56(8):608-616. PubMed ID: 28395118
[TBL] [Abstract][Full Text] [Related]
19. Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.
Li J; Dai Y; Wu L; Zhang M; Ouyang W; Huang J; Chen S
Front Med; 2021 Jun; 15(3):347-371. PubMed ID: 33400146
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia.
Burmeister T; Gökbuget N; Schwartz S; Fischer L; Hubert D; Sindram A; Hoelzer D; Thiel E
Haematologica; 2010 Feb; 95(2):241-6. PubMed ID: 19713226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
